455 related articles for article (PubMed ID: 27156867)
1. Monocyte programmed death ligand-1 expression after 3-4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study.
Shao R; Fang Y; Yu H; Zhao L; Jiang Z; Li CS
Crit Care; 2016 May; 20(1):124. PubMed ID: 27156867
[TBL] [Abstract][Full Text] [Related]
2. Monocyte Programmed Death Ligand-1, A Predicator for 28-Day Mortality in Septic Patients.
Tai H; Xing H; Xiang D; Zhu Z; Mei H; Sun W; Zhang W
Am J Med Sci; 2018 Apr; 355(4):362-367. PubMed ID: 29661350
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients.
Zhang Y; Li J; Lou J; Zhou Y; Bo L; Zhu J; Zhu K; Wan X; Cai Z; Deng X
Crit Care; 2011; 15(1):R70. PubMed ID: 21349174
[TBL] [Abstract][Full Text] [Related]
4. Predictive Value of Soluble Programmed Death-1 for Severe Sepsis and Septic Shock During the First Week in an Intensive Care Unit.
Zhao Y; Jia Y; Li C; Shao R; Fang Y
Shock; 2019 Mar; 51(3):289-297. PubMed ID: 29702526
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of programmed cell death 1 ligand 1 on neutrophils may be involved in sepsis-induced immunosuppression: an animal study and a prospective case-control study.
Wang JF; Li JB; Zhao YJ; Yi WJ; Bian JJ; Wan XJ; Zhu KM; Deng XM
Anesthesiology; 2015 Apr; 122(4):852-63. PubMed ID: 25437496
[TBL] [Abstract][Full Text] [Related]
6. The role of soluble thrombomodulin in the risk stratification and prognosis evaluation of septic patients in the emergency department.
Yin Q; Liu B; Chen Y; Zhao Y; Li C
Thromb Res; 2013 Oct; 132(4):471-6. PubMed ID: 24035044
[TBL] [Abstract][Full Text] [Related]
7. PD-L1 Blockade Improves Survival in Sepsis by Reversing Monocyte Dysfunction and Immune Disorder.
Yang L; Gao Q; Li Q; Guo S
Inflammation; 2024 Feb; 47(1):114-128. PubMed ID: 37776443
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic significance of programmed death protein 1 and programmed death ligand-1, and cytotoxic T lymphocyte-associated molecule-4 in hepatocellular carcinoma.
Chang H; Jung W; Kim A; Kim HK; Kim WB; Kim JH; Kim BH
APMIS; 2017 Aug; 125(8):690-698. PubMed ID: 28493410
[TBL] [Abstract][Full Text] [Related]
9. Increased percentage of PD-L1
Jiang W; Li X; Wen M; Liu X; Wang K; Wang Q; Li Y; Zhou M; Liu M; Hu B; Zeng H
Crit Care; 2020 Oct; 24(1):617. PubMed ID: 33076951
[TBL] [Abstract][Full Text] [Related]
10. Monocyte programmed death ligand-1 expression is an early marker for predicting infectious complications in acute pancreatitis.
Pan T; Zhou T; Li L; Liu Z; Chen Y; Mao E; Li M; Qu H; Liu J
Crit Care; 2017 Jul; 21(1):186. PubMed ID: 28705256
[TBL] [Abstract][Full Text] [Related]
11. Increased Expression of Programmed Cell Death-1 in Regulatory T Cells of Patients with Severe Sepsis and Septic Shock: An Observational Clinical Study.
Liu Q; An L; Qi Z; Zhao Y; Li C
Scand J Immunol; 2017 Nov; 86(5):408-417. PubMed ID: 28888058
[TBL] [Abstract][Full Text] [Related]
12. Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients.
Guignant C; Lepape A; Huang X; Kherouf H; Denis L; Poitevin F; Malcus C; Chéron A; Allaouchiche B; Gueyffier F; Ayala A; Monneret G; Venet F
Crit Care; 2011; 15(2):R99. PubMed ID: 21418617
[TBL] [Abstract][Full Text] [Related]
13. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis.
Chang K; Svabek C; Vazquez-Guillamet C; Sato B; Rasche D; Wilson S; Robbins P; Ulbrandt N; Suzich J; Green J; Patera AC; Blair W; Krishnan S; Hotchkiss R
Crit Care; 2014 Jan; 18(1):R3. PubMed ID: 24387680
[TBL] [Abstract][Full Text] [Related]
14. [The prognostic role of the programmed death-1 expression on T lymphocytes in septic patients].
Xu C; Li L; Zhen JH; Zhou J; Gong SJ; Cai GL; Yan J
Zhonghua Nei Ke Za Zhi; 2020 Oct; 59(10):796-800. PubMed ID: 32987482
[No Abstract] [Full Text] [Related]
15. Programmed Cell Death-1/Programmed Death-ligand 1 Pathway: A New Target for Sepsis.
Liu Q; Li CS
Chin Med J (Engl); 2017 Apr; 130(8):986-992. PubMed ID: 28397730
[TBL] [Abstract][Full Text] [Related]
16. Notch Signaling Pathway Was Involved in Regulating Programmed Cell Death 1 Expression during Sepsis-Induced Immunosuppression.
Pan T; Liu Z; Yin J; Zhou T; Liu J; Qu H
Mediators Inflamm; 2015; 2015():539841. PubMed ID: 26063974
[TBL] [Abstract][Full Text] [Related]
17. Increased PD-1 Expression and Altered T Cell Repertoire Diversity Predict Mortality in Patients with Septic Shock: A Preliminary Study.
Tomino A; Tsuda M; Aoki R; Kajita Y; Hashiba M; Terajima T; Kano H; Takeyama N
PLoS One; 2017; 12(1):e0169653. PubMed ID: 28072859
[TBL] [Abstract][Full Text] [Related]
18. The risk stratification and prognostic evaluation of soluble programmed death-1 on patients with sepsis in emergency department.
Zhao Y; Jia Y; Li C; Fang Y; Shao R
Am J Emerg Med; 2018 Jan; 36(1):43-48. PubMed ID: 28716595
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of programmed death-ligand 1 and programmed death-1 on antigen-presenting cells as a predictor of organ dysfunction and mortality during early sepsis: a prospective cohort study.
Li JB; Xie MR; Duan ML; Yu YN; Hang CC; Tang ZR; Li CS
World J Emerg Med; 2023; 14(3):179-185. PubMed ID: 37152526
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study.
Wilson JK; Zhao Y; Singer M; Spencer J; Shankar-Hari M
Crit Care; 2018 Apr; 22(1):95. PubMed ID: 29661225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
